Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: TRAVERE THERAPEUTICS, INC.
Awarding agency: Department of Veterans Affairs / Department of Veterans Affairs
Funding agency: Department of Veterans Affairs / Department of Veterans Affairs
Period of performance: 2024-04-01 to 2025-03-31
Current total value of award: $200552
Description: CHENODAL 250MG (CHENODIOL) PHARMACY